Selon l'analyse de par BIOTECanada et PricewaterhousCoopers, plus de 25% des compagnie "biopharma" Canadiennes vont mettre fin à leurs opérations d'ici la fin de l'année.Une statistique désolante!
Voilà...ici au Québec nous-en avons une qui semble bien se tirer d'affaire....
pour l'instant.....
Ils sont dans les tests diagnostic moléculaire pour le cancer.
Deux produits vedettes,le "PCa3" pour la prostate et le "Prévistage" pour le cancer colorectale.
Les ventes du premier était de 262 000$ en 2008 et déjà 132 000$ pour les 3 premiers mois de 2009.Ça va bien....
Ils ont vendus 24 tests de Prévistage à 3 500$ depuis sa sortie.
À la recherche d'une alliance stratégique et avec 17 millions de dollars en cash,CUR.to a selon des analystes 2½ - 3 ans pour devenir une compagnie rentable.
------------------------------------DIAGNOCURE TO HOST Q2 2009 EARNINGS CONFERENCE CALL AND WEBCAST
DiagnoCure Inc. will release its financial results for the second quarter of 2009, June 8, at approximately 4:30 p.m. ET.
The release will be followed by a conference call, which will be held on June 9, at 10 a.m. ET. The conference will begin with a brief presentation, followed by a question-and-answer period. The event will be webcast live through DiagnoCure's website, through a link on the Investors page, "Presentations and conferences."
For those who wish to take part in the conference call for the question and answer period, please dial 514-807-8791 (in the Montreal area), 416-644-3414 (in the Toronto area) or the toll-free number, 800-733-7560. For those unable to participate, a replay of the audio conference will also be available on DiagnoCure's website as at June 11, 2009, also through a link on the Investors page, "Presentations and conferences."
DiagnoCure Inc. will release its financial results for the second quarter of 2009, June 8, at approximately 4:30 p.m. ET.
The release will be followed by a conference call, which will be held on June 9, at 10 a.m. ET. The conference will begin with a brief presentation, followed by a question-and-answer period. The event will be webcast live through DiagnoCure's website, through a link on the Investors page, "Presentations and conferences."
For those who wish to take part in the conference call for the question and answer period, please dial 514-807-8791 (in the Montreal area), 416-644-3414 (in the Toronto area) or the toll-free number, 800-733-7560. For those unable to participate, a replay of the audio conference will also be available on DiagnoCure's website as at June 11, 2009, also through a link on the Investors page, "Presentations and conferences."
Aucun commentaire:
Enregistrer un commentaire